Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

ANGELA C WEYAND

Allopathic & Osteopathic Physicians Pediatrics Pediatric Hematology-Oncology

NPI
1558685180
CMS profile
1204699
Location
ANN ARBOR, MI

General Payments · PY2018–2024

$360,176.69

  • Reported across 245 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$104,367.20

48 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
GENZYME CORPORATION $55,387.15 24
F. Hoffmann-La Roche AG $13,807.12 5
Octapharma USA, Inc. $13,570.49 4
Genentech USA, Inc. $7,532.94 9
Takeda Pharmaceuticals U.S.A., Inc. $6,825.50 2
HEMA Biologics, LLC $3,350.00 1
PFIZER INC. $2,000.00 1
Bayer HealthCare Pharmaceuticals Inc. $1,394.00 1
Novo Nordisk AS $500.00 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $3,724.41 3
PY2019 $11,419.77 18
PY2020 $7,568.00 3
PY2021 $17,602.18 13
PY2022 $76,139.96 53
PY2023 $139,355.17 107
PY2024 $104,367.20 48

Payment records · PY2024 (48)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Bayer Healthcare Pharmaceuticals Inc. $1,394.00 03/19/2024 Consulting Fee Undisputed 01/23/2026 1086135159 CMS
F. Hoffmann-La Roche AG $8,360.00 10/10/2024 Consulting Fee Undisputed 01/23/2026 1132976913 CMS
F. Hoffmann-La Roche AG $382.75 10/10/2024 Travel and Lodging Undisputed 01/23/2026 1132976915 CMS
F. Hoffmann-La Roche AG $27.47 10/10/2024 Travel and Lodging Undisputed 01/23/2026 1132976917 CMS
F. Hoffmann-La Roche AG $382.75 10/10/2024 Food and Beverage Undisputed 01/23/2026 1132976919 CMS
F. Hoffmann-La Roche AG $4,654.15 10/10/2024 Travel and Lodging Undisputed 01/23/2026 1132976921 CMS
Genentech USA, Inc. $125.63 06/22/2024 Food and Beverage Undisputed 01/23/2026 1132976925 CMS
Genentech USA, Inc. $67.21 06/24/2024 Food and Beverage Undisputed 01/23/2026 1132976923 CMS
Genentech USA, Inc. $79.41 10/18/2024 Food and Beverage Undisputed 01/23/2026 1132976927 CMS
Genentech USA, Inc. $67.28 10/18/2024 Food and Beverage Undisputed 01/23/2026 1132976929 CMS
Genentech USA, Inc. $6,460.00 10/18/2024 Consulting Fee Undisputed 01/23/2026 1132976931 CMS
Genentech USA, Inc. $52.93 10/18/2024 Food and Beverage Undisputed 01/23/2026 1132976933 CMS
Genentech USA, Inc. $170.65 10/18/2024 Food and Beverage Undisputed 01/23/2026 1132976935 CMS
Genentech USA, Inc. $184.05 10/18/2024 Travel and Lodging Undisputed 01/23/2026 1132976937 CMS
Genentech USA, Inc. $325.78 10/18/2024 Travel and Lodging Undisputed 01/23/2026 1132976939 CMS
GENZYME CORPORATION $752.00 03/08/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1139840237 CMS
GENZYME CORPORATION $113.02 05/01/2024 Food and Beverage Undisputed 01/23/2026 1139840241 CMS
GENZYME CORPORATION $7,896.00 05/01/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1139840243 CMS
GENZYME CORPORATION $239.31 05/01/2024 Travel and Lodging Undisputed 01/23/2026 1139840245 CMS
GENZYME CORPORATION $546.20 05/01/2024 Travel and Lodging Undisputed 01/23/2026 1139840247 CMS
GENZYME CORPORATION $169.20 05/01/2024 Travel and Lodging Undisputed 01/23/2026 1139840249 CMS
GENZYME CORPORATION $12.45 05/01/2024 Food and Beverage Undisputed 01/23/2026 1139840251 CMS
GENZYME CORPORATION $2,632.00 05/03/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1139840239 CMS
GENZYME CORPORATION $14,530.88 05/25/2024 Travel and Lodging Undisputed 01/23/2026 1139840287 CMS
GENZYME CORPORATION $15,180.86 05/25/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1139840289 CMS
GENZYME CORPORATION $107.46 05/25/2024 Travel and Lodging Undisputed 01/23/2026 1139840291 CMS
GENZYME CORPORATION $198.44 05/25/2024 Travel and Lodging Undisputed 01/23/2026 1139840293 CMS
GENZYME CORPORATION $807.24 05/25/2024 Travel and Lodging Undisputed 01/23/2026 1139840295 CMS
GENZYME CORPORATION $84.18 05/25/2024 Food and Beverage Undisputed 01/23/2026 1139840297 CMS
GENZYME CORPORATION $53.11 05/25/2024 Food and Beverage Undisputed 01/23/2026 1139840299 CMS
GENZYME CORPORATION $43.84 05/25/2024 Food and Beverage Undisputed 01/23/2026 1139840301 CMS
GENZYME CORPORATION $52.92 05/25/2024 Food and Beverage Undisputed 01/23/2026 1139840303 CMS
GENZYME CORPORATION $114.58 08/12/2024 Food and Beverage Undisputed 01/23/2026 1139840259 CMS
GENZYME CORPORATION $4,888.00 08/12/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1139840261 CMS
GENZYME CORPORATION $2.00 08/12/2024 Travel and Lodging Undisputed 01/23/2026 1139840263 CMS
GENZYME CORPORATION $57.62 08/12/2024 Travel and Lodging Undisputed 01/23/2026 1139840265 CMS
GENZYME CORPORATION $2,078.00 10/15/2024 Consulting Fee Undisputed 01/23/2026 1139840305 CMS
GENZYME CORPORATION $2,632.00 10/17/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1139840273 CMS
GENZYME CORPORATION $2,195.84 10/22/2024 Consulting Fee Undisputed 01/23/2026 1139840285 CMS
HEMA Biologics, LLC $3,350.00 10/25/2024 Consulting Fee Undisputed 01/23/2026 1152820815 CMS
Novo Nordisk Inc $500.00 01/01/2024 Consulting Fee Undisputed 01/23/2026 1097041242 CMS
Octapharma USA, Inc. $2,056.72 09/28/2024 Honoraria Undisputed 01/23/2026 1142320604 CMS
Octapharma USA, Inc. $66.06 09/28/2024 Travel and Lodging Undisputed 01/23/2026 1142320606 CMS
Octapharma USA, Inc. $11,259.00 09/28/2024 Travel and Lodging Undisputed 01/23/2026 1142320608 CMS
Octapharma USA, Inc. $188.71 09/28/2024 Travel and Lodging Undisputed 01/23/2026 1142320610 CMS
PFIZER INC. $2,000.00 10/01/2024 Consulting Fee Undisputed 01/23/2026 1132011154 CMS
Takeda Pharmaceuticals U.S.A., Inc. $2,007.50 10/07/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1137697044 CMS
Takeda Pharmaceuticals U.S.A., Inc. $4,818.00 10/18/2024 Consulting Fee Undisputed 01/23/2026 1137697046 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.